Pittenger & Anderson Inc Abbott Laboratories Transaction History

Pittenger & Anderson Inc

$2.5 Billion
Q3 2024

A detailed history of Pittenger & Anderson Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Pittenger & Anderson Inc holds 95,464 shares of ABT stock, worth $11.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

95,464

Previous 94,995 0.49%

Holding current value

$11.2 Million

Previous $9.87 Million 10.26%

% of portfolio

0.44%

Previous 0.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$100.07 - $118.13 $46,932 - $55,402	469 Added 0.49%	95,464 $10.9 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $2.66 Million - $2.97 Million	26,455 Added 38.6%	94,995 $9.87 Million
Q1 2024 May 02, 2024	SELL	$109.52 - $120.96 $6,571 - $7,257	-60 Reduced 0.09%	68,540 $7.79 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $40,585 - $49,680	-450 Reduced 0.65%	68,600 $7.55 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $95,530 - $114,620	-1,000 Reduced 1.43%	69,050 $6.69 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $80,624 - $89,832	-800 Reduced 1.13%	70,050 $7.64 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $44,583 - $52,302	-469 Reduced 0.66%	70,850 $7.78 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $3,580 - $4,145	-37 Reduced 0.05%	71,319 $6.9 Million
Q2 2022 Jul 14, 2022	SELL	$102.07 - $123.37 $108,398 - $131,018	-1,062 Reduced 1.47%	71,356 $7.75 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $19,839 - $24,192	-174 Reduced 0.24%	72,418 $8.57 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $342,661 - $419,570	2,966 Added 4.26%	72,592 $10.2 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $142,908 - $158,098	1,225 Added 1.79%	69,626 $8.23 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $15,762 - $18,554	-149 Reduced 0.22%	68,401 $7.93 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $4,582 - $5,564	50 Added 0.07%	68,550 $7.46 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $38,285 - $49,000	500 Added 0.74%	68,500 $6.26 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $48,182 - $70,456	-767 Reduced 1.12%	68,000 $5.37 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $39,255 - $43,700	500 Added 0.73%	68,767 $5.97 Million
Q3 2018 Oct 12, 2018	BUY	$60.81 - $73.36 $9,121 - $11,004	150 Added 0.22%	68,267 $5.01 Million
Q2 2018 Aug 15, 2018	BUY	$57.57 - $63.54 $57,570 - $63,540	1,000 Added 1.49%	68,117 $4.15 Million
Q1 2018 May 08, 2018	SELL	$56.27 - $63.62 $11,254 - $12,724	-200 Reduced 0.3%	67,117 $4.02 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $169,092 - $181,030	3,150 Added 4.91%	67,317 $3.84 Million
Q2 2017 Aug 10, 2017	BUY	N/A	64,167	64,167 $3.12 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.

Account

Pittenger & Anderson Inc Abbott Laboratories Transaction History